全球医药领先品牌_肿瘤特效药_抗癌新药_靶向药物_全球医药咨询-【健康光环全球医药】

Gathering global pharmaceutical consulting services

A globally acclaimed online pharmaceutical consulting service platform

One stop online free answers for searching and consulting medicine

Provide globally advanced medical services

Provide you with better one-stop international medical services

Trustworthy health brands around you

Professional team provides attentive service

Professional medical team provides you with full process service guarantee

Professional medical team provides 24-hour free responsive service

Medicalhalo is a globally leading online pharmacy that collaborates with well-known pharmaceutical companies in Laos, India, Bangladesh, the United States, Germany, Japan, and other countries to provide cancer patients with global drug information consultation, drug purchase channels, overseas direct mail, overseas medical treatment, and other services

Medical big data

Recommended medication Popular drugs Global New Drugs

Palbonix

Retevmo

Naldemedine

Ritlecitinib

Lifnua

lemborexant

Remeron

Linospan

Remeron

Taltirelin-JG

Sawai

Lifnua

Eroxon gel

Retevmo

Taltirelin-JG

Ceredist

Taltirelin

Sawai

Palbonix

Eroxon gel

Retevmo

Ritlecitinib

Medical halo! Health protection and happiness!

Medical halo is a leading global online pharmacy that collaborates with well-known pharmaceutical companies in India, Bangladesh, the United States, Germany, Japan, and other countries to provide global drug information consultation, drug purchase channels, overseas direct mail, overseas medical treatment, and other services for cancer patients, helping them reduce their medication burden. Kanghule focuses on global cancer drug services and creates an efficient, convenient, and safe cross-border pharmaceutical service network platform. Health guards happiness, health guards happiness!

News Blog

FDA approves Takeda’s Alunbrig (brigatinib) as a new first-line treatment option for ALK

CAMBRIDGE, Mass. and OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceuticals, Inc. today announced that the U.S.

Check Details

Is Pralsetinib available in China?

RET fusion-positive thyroid cancer: advanced or metastatic thyroid cancer that requires systemic treatment

Check Details

How to take Lurbinectedin

Rupitidine is only for intravenous injection. Check for particulate matter and discoloration before administration. Do not administer if observed. Rupitidine can be administered with or without an in-line filter. If an in-line filter is used, a polyethersulfone in-line filter with a pore size of 0.22 micron is recommended. Consider the use of a central venous catheter, especially in patients with limited venous access, to reduce the risk of extravasation.

Check Details

Detailed instructions for Sotorasib: indications, usage and dosage, side effects, precautions

Sotorasib, a specific inhibitor of oral KRAS G12C launched by Amgen in the United States, was approved for marketing for the first time under the accelerated channel of the US FDA on May 28, 2021. It was first used to treat patients with KRAS Patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with G12C mutations mark the advent of oral targeted therapy for KRAS-mutated lung cancer. ‌

Check Details

Indications of Talatumumab

Talatuzumab is an innovative bispecific antibody drug developed by Amgen of the United States for the treatment of extensive-stage small cell lung cancer (ES-SCLC) that has progressed after platinum-containing chemotherapy.

Check Details

How much does a box of talatumumab cost

Talatuzumab is a DLL3/CD3 bispecific antibody drug developed by the American company Amgen. It can guide T cells directly to abnormal cells, activate T cells and prompt them to release cytotoxic substances, thereby killing abnormal cells. Understanding drug prices, treatment costs, and efficacy performance can help patients make financial plans and treatment expectations. This article will introduce in detail the price of a single box of talatumumab, the cost of a complete course of treatment, and clinical efficacy data to provide readers with a comprehensive medication reference.

Check Details

Can larotrectinib effectively treat the disease?

Introduction: On November 26, 2018, the U.S. Food and Drug Administration granted accelerated approval to larotrectinib for the treatment of adult and pediatric patients with solid tumors that have neurotrophic receptor tyrosine kinase (NTRK) gene fusions, no known acquired resistance mutations, have metastasized or where surgical resection may result in severe morbidity, and have no satisfactory alternative treatments or whose cancer has progressed after treatment.

Check Details

How to treat side effects caused by sotorasib?

is a new targeted therapy drug targeting the KRAS G12C mutation. Although it has shown significant efficacy in treating specific types of cancer, like most anti-cancer drugs, it may also be associated with a series of side effects. During treatment, patients may experience gastrointestinal reactions and other discomforts, which can be treated under the guidance of a doctor.

Check Details

View all

Popular medicines